Activated Charcoal May Delay Hyperphosphatemia
In a 2-phased trial, hyperphosphatemia and is sequelae developed in a smaller proportion of patients taking activated charcoal compared with placebo recipients.
American Urological Association Annual Meeting
Worse Survival After Robotic Cystectomy Seen at Low-Volume Centers
The researchers found lower overall survival among patients undergoing robot-assisted radical cystectomy at hospitals performing 10 or fewer procedures during 2010 to 2012.
MRI Accuracy for Prostate Cancer Challenged
Systematic biopsies always should be performed in conjunction with targeted biopsy in men with suspected clinically significant PCa at mpMRI.
Novel PSA Assay Improves Prostate Cancer Diagnosis
The new test, IsoPSA, measures all PSA isoforms in serum and more accurately discriminates high-grade cancer from benign disease.
Pure Bladder Cancer Variants Linked to Worse Survival After RC
Patients with a pure variant had significantly lower survival odds than those with pure urothelial carcinoma over a median 6.5 years of follow up.
Real-World mUCB Patient Survival Worse Than in Clinical Trials
Just 1 in 4 patients diagnosed with metastatic urothelial carcinoma of the bladder survive for a year, according to US national registry data.
Robot-assisted Radical Cystectomy on the Rise
By 2014 to 2015, 1 in 3 bladder cancer surgical procedures performed in the United States were robot-assisted.
Neoadjuvant Chemo Benefits Some Variant MIBC Patients
Researchers find prolonged survival among patients with neuroendocrine muscle-invasive bladder cancer.
Post-chemo PD-L1 Tied to Worse Prognosis in Bladder Cancer Pts
Five-year cancer-specific survival rates were 48.1% and 69.6% for PD-L1 positive and negative patients, respectively.
AUA Releases Updated Renal Mass Guidelines
The document spells out in greater detail the criteria for radical and partial nephrectomy and for placing patients on active surveillance.
Want to read more?
Please login or register first to view this content.